ARQT Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $129.86M ; Revenue including tax $129.86M ; Cost of revenue $10.94M ; Research and development $20.36M . 2026-03-31: Revenue $105.40M ; Revenue including tax $105.40M ; Cost of revenue $9.78M ; Research and development $30.63M . 2025-12-31: Revenue $129.50M* ; Revenue including tax $127.50M* ; Cost of revenue $11.69M* ; Research and development $20.45M* . 2025-09-30: Revenue $99.22M ; Revenue including tax $99.22M ; Cost of revenue $8.69M ; Research and development $19.60M . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
ARQT revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. ZORYVE Cream0.05 $2.93M ZORYVE Cream0.15 $24.23M ZORYVE Cream0.3 $35.33M ZORYVE Foam $67.38M Revenue $129.86M Cost of revenue $10.94M Operating income $16.43M Other income, net -$157.00K Research & development $20.36M Selling, general & administrative $82.14M Income tax $136.00K Net income $15.01M
Segment Separate filed amounts; connecting flows are not established. Components and totals may overlap.
ARQT revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Reportable Segment $129.86M Revenue $129.86M Cost of revenue $10.94M Operating income $16.43M Other income, net -$157.00K Research & development $20.36M Selling, general & administrative $82.14M Income tax $136.00K Net income $15.01M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Revenue including tax Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $129.86M $129.86M $10.94M $20.36M $82.14M (m) $136.00K $15.01M 2026-03-31 $105.40M $105.40M $9.78M $30.63M $74.08M (m) $93.00K -$11.29M 2025-12-31 $129.50M* $127.50M* $11.69M* $20.45M* $78.98M* (m) $470.00K* $17.39M* 2025-09-30 $99.22M $99.22M $8.69M $19.60M $62.40M (m) $80.00K $7.41M 2025-06-30 $81.50M $81.50M $7.49M $19.45M $69.17M (m) $342.00K -$15.89M 2025-03-31 $65.85M $63.85M $8.83M $17.54M $64.00M (m) $279.00K -$25.06M 2024-09-30 $44.76M $44.76M $5.50M $19.50M $58.82M (m) $0.00 -$41.54M 2024-06-30 $30.86M $30.86M $3.46M $19.30M $58.17M (m) $0.00 -$52.33M 2024-03-31 $49.57M $21.57M $3.26M $23.14M $54.79M (m) $324.00K -$35.38M 2023-09-30 $38.11M $8.11M $1.18M $26.24M $47.59M $75.01M $3.02M -$44.77M 2023-06-30 $5.19M $4.77M $776.00K $25.22M $45.96M $71.95M $0.00 -$70.99M 2023-03-31 $2.78M $2.78M $783.00K $35.34M $42.92M $79.05M $0.00 -$80.10M 2022-09-30 (m) $725.00K (m) $69.73M $35.47M $105.47M $0.00 -$107.71M 2022-06-30 $0.00 $0.00 (m) $38.20M $27.62M $65.83M (m) -$67.41M 2022-03-31 (m) $0.00 (m) $40.62M $22.01M $62.63M (m) -$64.32M 2021-09-30 (m) $0.00 (m) $40.60M $16.47M $57.08M (m) -$56.98M 2021-06-30 (m) (m) (m) $30.77M (m) $42.08M (m) -$42.01M 2021-03-31 (m) (m) (m) $21.63M (m) $36.09M (m) -$36.04M 2020-12-31 (m) (m) (m) (m) (m) $34.06M (m) -$34.05M 2020-09-30 (m) (m) (m) $32.74M (m) $38.30M (m) -$38.20M 2020-06-30 (m) (m) (m) $30.01M (m) $35.63M (m) -$35.41M 2020-03-31 (m) (m) (m) $25.18M (m) $28.65M (m) -$28.01M 2019-12-31 (m) (m) (m) (m) (m) $12.99M (m) -$12.57M 2019-09-30 (m) (m) (m) $12.35M (m) $14.65M (m) -$14.48M 2019-06-30 (m) (m) (m) $7.21M (m) $8.54M (m) -$8.29M 2019-03-31 (m) (m) (m) $6.20M (m) $6.95M (m) -$6.66M
Revenue and expense 6 month Period end Revenue Revenue including tax Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $235.26M $235.26M $20.72M $50.98M $156.21M (m) $229.00K $3.71M 2025-06-30 $147.35M $145.35M $16.32M $37.00M $133.17M (m) $621.00K -$40.95M 2024-06-30 $80.43M $52.43M $6.72M $42.44M $112.97M (m) $324.00K -$87.71M 2023-06-30 $7.97M $7.55M $1.56M $60.56M $88.88M $151.00M $0.00 -$151.09M 2022-06-30 $0.00 $0.00 (m) $78.83M $49.63M $128.46M (m) -$131.73M 2021-06-30 (m) (m) (m) $52.40M (m) $78.17M (m) -$78.05M 2020-06-30 (m) (m) (m) $55.19M (m) $64.28M (m) -$63.42M 2019-06-30 (m) (m) (m) $13.42M (m) $15.49M (m) -$14.95M
Revenue and expense 9 month Period end Revenue Revenue including tax Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-09-30 $246.57M $244.57M $25.01M $56.60M $195.58M (m) $701.00K -$33.54M 2024-09-30 $125.18M $97.18M $12.22M $61.94M $171.78M (m) $324.00K -$129.25M 2023-09-30 $46.08M $15.66M $2.74M $86.80M $136.47M $226.01M $3.09M -$195.86M 2022-09-30 (m) $725.00K (m) $148.56M $85.10M $233.93M $0.00 -$239.44M 2021-09-30 (m) $0.00 (m) $93.00M $42.24M $135.24M (m) -$135.03M 2020-09-30 (m) (m) (m) $87.93M (m) $102.58M (m) -$101.63M 2019-09-30 (m) (m) (m) $25.77M (m) $30.14M (m) -$29.43M
Revenue and expense 12 month Period end Revenue Revenue including tax Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-12-31 $376.07M $372.07M $36.70M $77.05M $274.55M (m) $1.17M -$16.14M 2024-12-31 $196.54M $166.54M $19.13M $76.42M $229.39M (m) $647.00K -$140.04M 2023-12-31 $59.61M $29.19M $4.99M $110.58M $185.15M (m) $3.11M -$262.14M 2022-12-31 $3.69M $3.69M $754.00K $182.44M $122.12M $305.31M $0.00 -$311.46M 2021-12-31 (m) $0.00 $0.00 $145.56M $60.97M $206.53M $0.00 -$206.36M 2020-12-31 (m) $0.00 (m) $115.31M (m) $136.65M $0.00 -$135.68M 2019-12-31 (m) (m) (m) $36.52M (m) $43.13M $0.00 -$42.00M 2018-12-31 (m) (m) (m) $17.94M (m) $19.73M $0.00 -$19.25M